World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
70
Citations
17334
World Ranking
1425
National Ranking
725

Overview

Shiv Srivastava is affiliated with the Uniformed Services University of the Health Sciences in the United States. Their research focuses extensively on prostate cancer, encompassing treatment, diagnosis, and prognosis through molecular and genetic approaches.

Their recent research output includes several papers published between 2020 and 2023, reflecting work in translational medicine and oncology-related specialties. Notable publications include:

  • Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer, 2020, Journal of Translational Medicine
  • A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry, 2020, European Urology
  • Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry, 2023, European Urology
  • A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy, 2020, The Journal of Urology
  • African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer, 2020, International Journal of Cancer

Their frequent co-authors include:

  • György Petrovics
  • Albert Dobi
  • Inger L. Rosner
  • Isabell A. Sesterhenn
  • Jennifer Cullen

Shiv Srivastava has contributed multiple publications to key scientific venues, such as:

  • Cancer Epidemiology Biomarkers & Prevention
  • Brachytherapy
  • Cancer Research
  • European Urology
  • The Journal of Urology

Their main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with specific work in subfields such as:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Oncology
  • Radiology, Nuclear Medicine and Imaging

Shiv Srivastava's research covers a range of topics including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Molecular Biology Techniques and Applications
  • DNA Repair Mechanisms
  • Cancer Genomics and Diagnostics
  • Ferroptosis and cancer prognosis

Best Publications

  • Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

    Shiv Srivastava;Zhiqiang Zou;Kathleen Pirollo;William Blattner

  • Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT–Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens

    Jun Miki;Bungo Furusato;Hongzhen Li;Yongpeng Gu

  • Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

    Yasuhito Yuasa;Shiv K. Srivastava;Claire Y. Dunn;Johng S. Rhim

  • PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

    Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

    Markku Miettinen;Zeng-Feng Wang;Anders Paetau;Shyh-Han Tan

  • Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

    John J. Bauer;Isabell A. Sesterhenn;F.K. Mostofi;David G. McLeod

  • Elevated expression of PCGEM1 , a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients

    Gyorgy Petrovics;Wei Zhang;Mazen Makarem;Jesse P Street

  • A long noncoding RNA connects c-Myc to tumor metabolism

    Chiu Lien Hung;Ling Yu Wang;Yen Ling Yu;Hong Wu Chen

  • Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.

    Unknown

  • Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors

    Jun Fujita;Shiv K. Srivastava;Matthias H. Kraus;Johng S. Rhim

  • Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate Cancer

    Howard B. Heidenberg;Isabell A. Sesterhenn;Jaya P. Gaddipati;Christopher M. Weghorst

  • Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.

    Keiichiro Nakamura;Yutaka Yasunaga;Takehiko Segawa;Daejin Ko

  • A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in Prostate

    Linda L. Xu;Naga Shanmugam;Takehiko Segawa;Isabell A. Sesterhenn

  • ANX7, a candidate tumor suppressor gene for prostate cancer

    Meera Srivastava;Lukas Bubendorf;Vasantha Srikantan;Linda Fossom

  • Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer

    Lionel L. Bañez;Premkala Prasanna;Leon Sun;Amina Ali

  • Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes.

    Linda L. Xu;Yong Ping Su;Ron Labiche;Takehiko Segawa

  • Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

    Takehiko Segawa;Martin E Nau;Linda L Xu;Rao N Chilukuri

  • Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.

    Caroline Craig;Min Kim;Ekta Ohri;Robert Wersto

  • Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.

    D Katayose;J Gudas;H Nguyen;S Srivastava

Frequent Co-Authors

David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Isabell A. Sesterhenn
Isabell A. Sesterhenn United States Army Research Laboratory
Judd W. Moul
Judd W. Moul Duke University
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital
Matthew L. Freedman
Matthew L. Freedman Harvard University
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Karin D. Rodland
Karin D. Rodland Pacific Northwest National Laboratory
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
James L. Mohler
James L. Mohler Roswell Park Cancer Institute
Robin J. Leach
Robin J. Leach The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students with a background in molecular biology often consider expanding their career prospects with online degrees in health and life sciences. If you’re interested in communication sciences, speech pathology bridge programs offer a pathway for non-SLP majors to transition into speech-language pathology, equipping graduates for rewarding roles in healthcare and education.

Nursing is another direction, with programs tailored for those from non-nursing backgrounds. The best online bsn programs for non nurses provide accelerated study options, making it possible to earn a nursing degree efficiently and flexibly. Molecular biology graduates can leverage their scientific knowledge in these programs, enhancing their qualifications in clinical settings.

Career advancement is also possible through the nurse practitioner route. Prospective students often ask how much does a psychiatric nurse practitioner make, as this specialized role offers both high earning potential and meaningful patient care. Wondering how long does it take to be a nurse practitioner? Fast-track programs and online options can help you enter this in-demand career sooner than you might expect.

Best Scientists Citing Shiv Srivastava

Trending Scientists